{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:36:36Z","timestamp":1791394596945,"version":"4.3.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011643","name":"Secretar\u00eda de Agricultura, Ganader\u00eda, Desarrollo Rural, Pesca y Alimentaci\u00f3n","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011643","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0236879","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T14:10:54Z","timestamp":1597327854000},"page":"e0236879","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5\u03b1- reductase type 2 and induced cell apoptosis"],"prefix":"10.1371","volume":"15","author":[{"given":"Shanika","family":"Karunasagara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geum-Lan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungwon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6355-5738","authenticated-orcid":true,"given":"Ju-Young","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"pone.0236879.ref001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0031-9422(97)00588-8","article-title":"A phenolic glycoside and triterpenoids from stauntonia hexaphylla","volume":"47","author":"HB Wang","year":"1998","journal-title":"Phytochemistry"},{"key":"pone.0236879.ref002","article-title":"Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression","volume":"15","author":"YH Cheon","year":"2015","journal-title":"BMC Compliment Altern Med"},{"key":"pone.0236879.ref003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"G Marino","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"pone.0236879.ref004","first-page":"4273257","article-title":"Inhibitory activities of Stauntonia hexaphylla leaf constituents on rat lens aldose reductase and formation of advanced glycation end products and antioxidant","volume":"2017","author":"SH Hwang","journal-title":"Biomed. Res"},{"key":"pone.0236879.ref005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bmcl.2019.02.022","article-title":"Isolation, structural elucidation, and insights into the anti-inflammatory effects of triterpene saponins from the leaves of stauntonia hexaphylla","volume":"29","author":"LB Vinh","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"pone.0236879.ref006","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.bmcl.2019.07.010","article-title":"Bioactive triterpene glycosides from the fruit of Stauntonia hexaphylla and insights into the molecular mechanism of its inflammatory effects","volume":"29","author":"LB Vinh","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"pone.0236879.ref007","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-018-0191-z","article-title":"Corni Fructus: a review of chemical constituents and pharmacological activities","volume":"13","author":"Y Dong","year":"2018","journal-title":"Chinese Medicine"},{"key":"pone.0236879.ref008","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00894","article-title":"Cornus mas and Cornus officinalis- Analogies and Differences of Two Medicinal Plants Traditionally Used","volume":"9","author":"ME Czerwinska","year":"2018","journal-title":"Front Pharmacol"},{"key":"pone.0236879.ref009","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4162\/nrp.2018.12.5.378","article-title":"Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5\u03b1-reductase and androgen receptor expression in rats","volume":"12","author":"H Hwangbo","year":"2018","journal-title":"Nutr Res Pract"},{"key":"pone.0236879.ref010","doi-asserted-by":"crossref","first-page":"112446","DOI":"10.1016\/j.jep.2019.112446","article-title":"The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5\u03b1-reductase type 2","volume":"250","author":"GL Hong","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"pone.0236879.ref011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exger.2004.12.008","article-title":"Benign prostatic hyperplasia: age-related tissue remodeling","volume":"40","author":"G Untergasser","year":"2005","journal-title":"Exp Gerontol"},{"key":"pone.0236879.ref012","first-page":"S3","article-title":"Pathophysiology of lower urinary tract symptoms in the aging male population","volume":"7","author":"H Lepor","year":"2005","journal-title":"Rev Urol"},{"key":"pone.0236879.ref013","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2003.08.015","article-title":"Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)","volume":"44","author":"R Rosen","year":"2003","journal-title":"Eur. Urol"},{"key":"pone.0236879.ref014","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bju.12745","article-title":"Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)\u2014focus on the UK","volume":"115","author":"M Speakman","year":"2015","journal-title":"BJU Int"},{"key":"pone.0236879.ref015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","article-title":"Androgens and estrogens in benign prostatic hyperplasia: past, present and future","volume":"82","author":"TM Nicholson","year":"2011","journal-title":"Differentiation"},{"key":"pone.0236879.ref016","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.ju.0000139539.94828.29","article-title":"Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia","volume":"172","author":"G Andriole","year":"2004","journal-title":"J Urol"},{"key":"pone.0236879.ref017","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.fct.2012.01.007","article-title":"Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia","volume":"50","author":"IS Shin","year":"2012","journal-title":"Food Chem. Toxicol"},{"key":"pone.0236879.ref018","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MOU.0b013e32834d9bfd","article-title":"Alpha-blockers for benign prostatic hyperplasia: the new era","volume":"22","author":"G Lepor","year":"2012","journal-title":"Curr. Opin. Urol"},{"issue":"Suppl. 1","key":"pone.0236879.ref019","first-page":"10","article-title":"Benign prostatic hyperplasia (BPH) management in the primary care setting","volume":"19","author":"A Kappor","year":"2012","journal-title":"Can. J. Urol"},{"key":"pone.0236879.ref020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00345-009-0493-y","article-title":"Current status of 5\u03b1-reductase inhibitors in the management of lower urinary tract symptoms and BPH","volume":"28","author":"S Gravas","year":"2010","journal-title":"World J. Urol"},{"key":"pone.0236879.ref021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/aps.2009.1","article-title":"Pharmacological effects of Saw palmetto extract in the lower urinary tract","volume":"30","author":"M Suzuki","year":"2009","journal-title":"Acta pharmacol sin"},{"key":"pone.0236879.ref022","first-page":"134","article-title":"Saw Palmetto Berry as a Treatment for BPH","volume":"3","author":"E Fagelman","year":"2001","journal-title":"Rev Urol"},{"key":"pone.0236879.ref023","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/ptr.5406","article-title":"Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia","volume":"29","author":"J Colado\u2010Vel\u00e1zquez","year":"2015","journal-title":"Phytother. Res"},{"key":"pone.0236879.ref024","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.eursup.2009.11.005","article-title":"Serenoa repens: the scientific basis for the treatment of benign prostatic hyperplasia","volume":"8","author":"FK Habib","year":"2009","journal-title":"Eur Urol Suppl"},{"key":"pone.0236879.ref025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1517\/14728214.11.1.111","article-title":"Emerging drug therapies for benign prostatic hyperplasia","volume":"11","author":"TL Bullock","year":"2006","journal-title":"Expert Opin Emerg Drugs"},{"key":"pone.0236879.ref026","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1743-6109.2010.02157.x","article-title":"Adverse side effects of 5\u03b1-reductase inhibitors therapy: Persistent diminished libido and erectile dysfunction and depression in a subset of patients","volume":"8","author":"AM Traish","year":"2011","journal-title":"J Sex Med"},{"key":"pone.0236879.ref027","first-page":"396","article-title":"Social controls on cell survival and cell death","volume":"256","author":"MC Raft","year":"1992","journal-title":"Nature"},{"key":"pone.0236879.ref028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G","article-title":"Induction of Apoptosis and Inhibition of Cell Proliferation by the Lipido-Sterolic Extract of Serenoa repens (LSESr, PermixonT) in Benign Prostatic Hyperplasia","volume":"45","author":"F Vacherot","year":"2000","journal-title":"The Prostate"},{"key":"pone.0236879.ref029","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3390\/molecules23102638","article-title":"Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia","volume":"23","author":"BR Jin","year":"2018","journal-title":"Molecules"},{"key":"pone.0236879.ref030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"IM Thompson","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"pone.0236879.ref031","first-page":"276","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"AH Cynthia","year":"1997","journal-title":"Endocr. Rev"},{"issue":"Suppl.8","key":"pone.0236879.ref032","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eursup.2009.11.002","article-title":"Benign prostatic hyperplasia and its aetiologies","author":"A Briganti","year":"2009","journal-title":"Eur. Urol"},{"key":"pone.0236879.ref033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00126839-200607040-00003","article-title":"Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats","volume":"7","author":"ML Arruzazabala","year":"2006","journal-title":"Drugs R D"},{"key":"pone.0236879.ref034","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jep.2014.09.007","article-title":"Treatment of benign prostatic hyperplasia with Croton Membranaceus in an experimental animal model","volume":"157","author":"DK Afriyie","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"pone.0236879.ref035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ecl.2011.05.012","article-title":"Overview of prostate anatomy, histology, and pathology","volume":"40","author":"CH Lee","year":"2011","journal-title":"Endocrinol. Metab. Clin. North Am"},{"key":"pone.0236879.ref036","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-08-3795","article-title":"A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth","volume":"69","author":"Z Guo","year":"2009","journal-title":"Cancer Res"},{"key":"pone.0236879.ref037","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0303-7207(96)03819-1","article-title":"A and B forms of the androgen receptor are expressed in a variety of human tissues","volume":"120","author":"CM Wilson","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"pone.0236879.ref038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1026057402945","article-title":"The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer","volume":"253","author":"B Chatterifee","year":"2003","journal-title":"Mol. Cell. Biochem"},{"key":"pone.0236879.ref039","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ajpath.2013.02.028","article-title":"Androgen receptor roles in the development of benign prostate hyperplasia","volume":"182","author":"K Izumi","year":"2013","journal-title":"Am. J. Pathol"},{"key":"pone.0236879.ref040","first-page":"13","article-title":"Is there a link between BPH and prostate cancer?","volume":"256","author":"RT Chang","year":"2012","journal-title":"Practitioner"},{"key":"pone.0236879.ref041","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0039-128X(97)00042-1","article-title":"Kinetic analysis of androstenedione 5\u03b1-reductase in epithelium and stroma of human prostate","volume":"62","author":"W Heike","year":"1997","journal-title":"Steroids"},{"key":"pone.0236879.ref042","volume-title":"Pathologic Basis of Veterinary Disease","author":"JF Zachary","year":"2012","edition":"5"},{"key":"pone.0236879.ref043","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12859-015-0618-9","article-title":"Discrimination of cell cycle phases in PCNA-immunolabeled cells","volume":"16","author":"F Schonenberger","year":"2015","journal-title":"BMC Bioinforma"},{"key":"pone.0236879.ref044","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.041619798","article-title":"Solution structure of the antiapoptotic protein bcl-2","volume":"98","author":"AM Petros","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"pone.0236879.ref045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/369321a0","article-title":"BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax","volume":"369","author":"XM Yin","year":"1994","journal-title":"Nature"},{"key":"pone.0236879.ref046","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tcb.2007.10.003","article-title":"The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology","volume":"18","author":"C Hetz","year":"2008","journal-title":"Trends Cell Biol"},{"key":"pone.0236879.ref047","first-page":"939","article-title":"The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy","volume":"16","author":"D Xu","year":"2017","journal-title":"Excli Journal"},{"key":"pone.0236879.ref048","first-page":"123","article-title":"Increased Bax\/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis","volume":"21","author":"S Salakou","year":"2007","journal-title":"In Vivo"},{"key":"pone.0236879.ref049","first-page":"S122","article-title":"BPH: Epidemiology and comorbidities","volume":"12","author":"KT McVary","year":"2006","journal-title":"Am J Manag Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T14:11:13Z","timestamp":1597327873000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0236879"}},"subtitle":[],"editor":[{"given":"Suresh","family":"Yenugu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0236879","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/819474","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]}}}